Bbridgman
Forum Replies Created
-
Posts
-
Hi Mary, Thanks very much for your response. You’ve confirmed my impression that no papers have been published recently (i.e. last year or two) on this subject. I did find one retrospective study on hypofractionated RT that showed promise, but nothing on ablative RT. One of Dr Crane’s co-authors who was principal investigator for the clinical trial that never took off is at Mass General, so we will reach out to him to determine if ablative RT for ICC is currently being practiced there. Also I’ll sit in on the CCF webinar this afternoon with Dr Goyal, also from MGH, to see if she offers any insights. Depending what we learn from MGH, it may be a good idea to contact Dr Crane at MSK. The CCF is such a valuable resource! Thank you. BetsyB
Hi Gavin, I had not read this PubMed article when I posted my message last night about the MD Anderson study. I’m glad to see this type of therapy is still being explored. It seems like such an attractive option, I am trying to figure out whether it is widely practiced, or routinely offered as an option to eligible patients. My brother in law is treated at Mass General, which is a leader in this field along with MD Anderson. Thanks. Betsy
Vtkb, Thank you for your suggestion. My brother-in-law is being treated at Mass General in Boston and his surgery consult was at Dana Farber. Are there other institutions in Boston/New England that “specialize” in this type of cancer? Thanks for your help. BetsyB
Bglass, Thank you so much for the suggestions and sources, they have advanced my searching and knowledge greatly. To answer your question, my brother-in-law’s cancer has not spread outside his liver. The tumor is located at the top of the liver surrounding blood vessels, which is why it is judged unresectable. So far he seems to be doing OK with the chemo, although it’s too soon to know whether or how much it’s helping. BetsyB
